Pharmacy and Poisons Board has withdrawn anti-acid Ranitidine, sold in Kenya as Neotack, from the market after the US Food and Drug Administration (FDA) found a carcinogenic substance in some samples.
Ranitidine is an over-the-counter drug to ease heartburn.
Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.
